A. Amanzada, I. A. Malik, M. Nischwitz, S. Sultan, N. Naz et al., Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflamed liver, Histochem. Cell Biol, vol.135, pp.305-315, 2011.

G. Baffy, E. M. Brunt, and S. H. Caldwell, Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace, J. Hepatol, vol.56, pp.1384-1391, 2012.

D. F. Calvisi, C. Wang, C. Ho, S. Ladu, S. A. Lee et al., Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma, Gastroenterology, vol.140, pp.1071-1083, 2011.

D. K. Deperalta, L. Wei, S. Ghoshal, B. Schmidt, G. Y. Lauwers et al., Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis, Cancer, vol.122, pp.1216-1227, 2016.

K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt et al., Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J. Clin. Invest, vol.115, pp.1343-1351, 2005.

D. F. Egan, D. B. Shackelford, M. M. Mihaylova, S. Gelino, R. A. Kohnz et al., Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy, Science, vol.331, pp.456-461, 2011.

N. Goossens, X. Sun, and Y. Hoshida, Molecular classification of hepatocellular carcinoma: potential therapeutic implications, Hepat. Oncol, vol.2, pp.371-379, 2015.

G. Harriman, J. Greenwood, S. Bhat, X. Huang, R. Wang et al., AcetylCoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats, Proc. Natl. Acad. Sci. USA, vol.113, pp.1796-1805, 2016.

M. K. Hellerstein, J. M. Schwarz, and R. A. Neese, Regulation of hepatic de novo lipogenesis in humans, Annu. Rev. Nutr, vol.16, pp.523-557, 1996.

Y. Hoshida, Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment, PLoS One, vol.5, 2010.

Y. Hoshida, S. M. Nijman, M. Kobayashi, J. A. Chan, J. P. Brunet et al., , 2009.

, Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma, Cancer Res, vol.69, pp.7385-7392

T. Ishimoto, M. A. Lanaspa, M. T. Le, G. E. Garcia, C. P. Diggle et al., Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice, Proc. Natl. Acad. Sci. USA, vol.109, pp.4320-4325, 2012.

S. Joshi-barve, S. S. Barve, K. Amancherla, L. Gobejishvili, D. Hill et al., Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes, Hepatology, vol.46, pp.823-830, 2007.

J. S. Kang, H. Wanibuchi, K. Morimura, F. J. Gonzalez, and S. Fukushima, Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo, Cancer Res, vol.67, pp.11141-11146, 2007.

R. Kumamoto, H. Uto, K. Oda, R. Ibusuki, S. Tanoue et al., Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat, Eur. J. Med. Res, vol.18, p.54, 2013.

J. M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane et al., Sorafenib in advanced hepatocellular carcinoma, SHARP Investigators Study Group, vol.359, pp.378-390, 2008.

J. M. Llovet, J. Zucman-rossi, E. Pikarsky, B. Sangro, M. Schwartz et al., Hepatocellular carcinoma, Nat. Rev. Dis. Primers, vol.2, p.16018, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01910322

J. D. Mcgarry, G. F. Leatherman, and D. W. Foster, Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonylCoA, J. Biol. Chem, vol.253, pp.4128-4136, 1978.

S. Nakagawa, L. Wei, W. M. Song, T. Higashi, S. Ghoshal et al., Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition, Precision Liver Cancer Prevention Consortium, vol.30, pp.879-890, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02312659

E. J. Park, J. H. Lee, G. Y. Yu, G. He, S. R. Ali et al., Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression, Cell, vol.140, pp.197-208, 2010.

K. Rahman, C. Desai, S. S. Iyer, N. E. Thorn, P. Kumar et al., Loss of junctional adhesion molecule A promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol, Gastroenterology, vol.151, pp.733-746, 2016.

N. B. Ruderman, D. Carling, M. Prentki, and J. M. Cacicedo, , 2013.

, AMPK, insulin resistance, and the metabolic syndrome, J. Clin. Invest, vol.123, pp.2764-2772

B. Schmidt, L. Wei, D. K. Deperalta, Y. Hoshida, P. S. Tan et al., Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition, Int. J. Cancer, vol.138, pp.1494-1505, 2016.

R. U. Svensson, S. J. Parker, L. J. Eichner, M. J. Kolar, M. Wallace et al., Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models, Nat. Med, vol.22, pp.1108-1119, 2016.

P. S. Tan, S. Nakagawa, N. Goossens, A. Venkatesh, T. Huang et al., Clinicopathological indices to predict hepatocellular carcinoma molecular classification, Liver Int, vol.36, pp.108-118, 2016.

L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-tieulent et al., Global cancer statistics, CA Cancer J. Clin, vol.65, pp.87-108, 2012.

C. Wang, S. Rajput, K. Watabe, D. F. Liao, and D. Cao, Acetyl-CoA carboxylase-a as a novel target for cancer therapy, Front. Biosci. (Schol. Ed.), vol.2, pp.515-526, 2010.

N. Yahagi, H. Shimano, K. Hasegawa, K. Ohashi, T. Matsuzaka et al., Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma, Eur. J. Cancer, vol.41, pp.1316-1322, 2005.

H. Zhao, V. Desai, J. Wang, D. M. Epstein, M. Miglarese et al., Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines, Mol. Cancer Ther, vol.11, pp.503-513, 2012.